These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38801782)

  • 1. Localized anaplastic lymphoma kinase-positive histiocytosis in a cerebellar hemisphere with long-term treatment: illustrative case.
    Kumagai E; Tanaka M; Iwasaki F; Yanagimachi M; Hirokawa D; Goto H; Tanaka Y
    J Neurosurg Case Lessons; 2024 May; 7(22):. PubMed ID: 38801782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multisystem ALK-positive histiocytosis: a multi-case study and literature review.
    Liu W; Liu HJ; Wang WY; Tang Y; Zhao S; Zhang WY; Yan JQ; Liu WP
    Orphanet J Rare Dis; 2023 Mar; 18(1):53. PubMed ID: 36915094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALK-positive Histiocytosis of the Breast: A Clinicopathologic Study Highlighting Spindle Cell Histology.
    Kashima J; Yoshida M; Jimbo K; Izutsu K; Ushiku T; Yonemori K; Yoshida A
    Am J Surg Pathol; 2021 Mar; 45(3):347-355. PubMed ID: 32826530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALK-positive histiocytosis with disseminated disease responded to alectinib: a case report.
    Tian Y; Li J; Liu B; Xie H; Zheng M; Yao W
    Ann Palliat Med; 2021 Sep; 10(9):10095-10101. PubMed ID: 34628929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.
    Kemps PG; Picarsic J; Durham BH; Hélias-Rodzewicz Z; Hiemcke-Jiwa L; van den Bos C; van de Wetering MD; van Noesel CJM; van Laar JAM; Verdijk RM; Flucke UE; Hogendoorn PCW; Woei-A-Jin FJSH; Sciot R; Beilken A; Feuerhake F; Ebinger M; Möhle R; Fend F; Bornemann A; Wiegering V; Ernestus K; Méry T; Gryniewicz-Kwiatkowska O; Dembowska-Baginska B; Evseev DA; Potapenko V; Baykov VV; Gaspari S; Rossi S; Gessi M; Tamburrini G; Héritier S; Donadieu J; Bonneau-Lagacherie J; Lamaison C; Farnault L; Fraitag S; Jullié ML; Haroche J; Collin M; Allotey J; Madni M; Turner K; Picton S; Barbaro PM; Poulin A; Tam IS; El Demellawy D; Empringham B; Whitlock JA; Raghunathan A; Swanson AA; Suchi M; Brandt JM; Yaseen NR; Weinstein JL; Eldem I; Sisk BA; Sridhar V; Atkinson M; Massoth LR; Hornick JL; Alexandrescu S; Yeo KK; Petrova-Drus K; Peeke SZ; Muñoz-Arcos LS; Leino DG; Grier DD; Lorsbach R; Roy S; Kumar AR; Garg S; Tiwari N; Schafernak KT; Henry MM; van Halteren AGS; Abla O; Diamond EL; Emile JF
    Blood; 2022 Jan; 139(2):256-280. PubMed ID: 34727172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of crizotinib based systemic treatment in ALK positive histiocytosis involving the central nervous system: a case report and literature review.
    He Q; Zhang W; Li Q
    BMC Pediatr; 2022 May; 22(1):308. PubMed ID: 35614430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case report: ALK-positive histiocytosis presented as bilateral synchronous breast masses with long-term remission on crizotinib.
    Zhou Y; Hurtado-Castillo M; Pandey O
    Front Med (Lausanne); 2023; 10():1288849. PubMed ID: 38093982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct Clinicopathologic Features and Possible Pathogenesis of Localized ALK-positive Histiocytosis of the Breast.
    Osako T; Kurisaki-Arakawa A; Dobashi A; Togashi Y; Baba S; Shiozawa S; Ishigame H; Ishige H; Ohno S; Ishikawa Y; Takeuchi K
    Am J Surg Pathol; 2022 Mar; 46(3):344-352. PubMed ID: 34482333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion.
    Chang KTE; Tay AZE; Kuick CH; Chen H; Algar E; Taubenheim N; Campbell J; Mechinaud F; Campbell M; Super L; Chantranuwat C; Yuen ST; Chan JKC; Chow CW
    Mod Pathol; 2019 May; 32(5):598-608. PubMed ID: 30573850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALK-positive histiocytosis in 12 Asian children.
    Feng X; Tao J; He N; Wang J; He L; Zhang N
    Hum Pathol; 2024 Oct; 152():105637. PubMed ID: 39117024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALK-rearranged histiocytosis: Report of two cases with involvement of the central nervous system.
    Rossi S; Gessi M; Barresi S; Tamburrini G; Giovannoni I; Ruggiero A; Colafati GS; Frassanito P; Carboni A; Alexandre A; Cacchione A; Trombatore P; Diomedi-Camassei F; Gaspari S; Gianno F; Marras CE; Cecinati V; Carai A; Mastronuzzi A; Alaggio R
    Neuropathol Appl Neurobiol; 2021 Oct; 47(6):878-881. PubMed ID: 34048085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALK-positive histiocytosis associated with chronic lymphocytic leukaemia/small lymphocytic lymphoma: a multitarget response under ibrutinib.
    Syrykh C; Ysebaert L; Péricart S; Evrard SM; Meggetto F; Kanoun S; Brousset P; Laurent C
    Virchows Arch; 2021 Apr; 478(4):779-783. PubMed ID: 33011863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding the Phenotype of ALK-positive Histiocytosis: A Report of 2 Cases.
    Huang H; Gheorghe G; North PE; Suchi M
    Pediatr Dev Pathol; 2018; 21(5):449-455. PubMed ID: 29224419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapy for advanced anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer.
    Cameron LB; Hitchen N; Chandran E; Morris T; Manser R; Solomon BJ; Jordan V
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013453. PubMed ID: 34994987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case Report: ALK-Positive Histiocytosis With
    Guo Y; Qu HB; Ning G; Jia FL; Liu H; Ma XM; Liao Y
    Front Oncol; 2022; 12():858939. PubMed ID: 35359354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategy for Pediatric Patients with Relapsed or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma: A Review.
    Noguchi K; Ikawa Y
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local ALK-Positive Histiocytosis With Unusual Morphology and Novel
    Tran TAN; Chang KTE; Kuick CH; Goh JY; Chang CC
    Int J Surg Pathol; 2021 Aug; 29(5):543-549. PubMed ID: 33243034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localized ALK-positive histiocytosis in a Chinese woman: report of a case in the lung with a novel EML4-ALK rearrangement.
    Bai Y; Sun W; Niu D; Yang X; Diao X; Yu Y; Lin D
    Virchows Arch; 2021 Dec; 479(6):1079-1083. PubMed ID: 33825946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaplastic lymphoma kinase inhibitor therapy in the treatment of inflammatory myofibroblastic tumors in pediatric patients: Case reports and literature review.
    Craig E; Wiltsie LM; Beaupin LK; Baig A; Kozielski R; Rothstein DH; Li V; Twist CJ; Barth M
    J Pediatr Surg; 2021 Dec; 56(12):2364-2371. PubMed ID: 33676744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaplastic large cell lymphoma, ALK-negative.
    Ferreri AJ; Govi S; Pileri SA; Savage KJ
    Crit Rev Oncol Hematol; 2013 Feb; 85(2):206-15. PubMed ID: 22789917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.